Sign in
ISO Stock Price, Chart, Stats & News
IsoPlexis Corporation
Save
30.28M
Market cap
–
Current P/E
–
Forward P/E
ISO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -5.52% |
Operating margin | -603.96% |
Pretax margin | -632.40% |
Net margin | -689.12% |
Effective tax rate | -8.97% |
ROA | -105.90% |
ROE | -125.88% |
D/E | 1.25x |
Interest coverage ratio | -18.95x |
ISO valuation
P/E | – |
P/S | 1.81x |
P/B | 0.73x |
P/CF | -0.31x |
P/FCF | -0.29x |
P/OCF | -0.31x |
PEG | -0.00x |
EV multiple | -0.18x |
About
IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform.
Similar securities
Based on sector and market capitalization
Report issue